Who to follow: HealthTech executives
EK
Emil Kakkis, MD, PhD
Founder, President and CEO · Ultragenyx Pharmaceutical
Pharma & Life SciencesNorth AmericaEstablished
Why follow Emil
Leads Ultragenyx’s development of therapies for rare and ultrarare diseases, including the approved MPS IIIA gene therapy Fayuvi.
Writes about
Rare DiseaseGene TherapyDrug Development
Best for
Rare-disease founders and drug developers